(Q39491238)

12 September 2017

title

Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer (English)

1 reference

12 September 2017

0 references

1 reference

Huqun

1

1 reference

12 September 2017

Rinako Ishikawa

2

1 reference

12 September 2017

Jialing Zhang

3

1 reference

12 September 2017

Hitoshi Miyazawa

4

1 reference

12 September 2017

Yoshiya Goto

5

1 reference

12 September 2017

Yoshihiko Shimizu

6

1 reference

12 September 2017

Koichi Hagiwara

7

1 reference

12 September 2017

Nobuyuki Koyama

8

1 reference

12 September 2017

language of work or name

English

0 references

publication date

11 August 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

118

1 reference

12 September 2017

issue

6

1 reference

12 September 2017

page(s)

1599-1606

1 reference

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

Gene silencing in cancer in association with promoter hypermethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

Epigenetics in human disease and prospects for epigenetic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

Cancer genes and the pathways they control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

Chromatin modifier enzymes, the histone code and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

Consequences of the depletion of zygotic and embryonic enhancer of zeste 2 during preimplantation mouse development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

Polycomb complexes repress developmental regulators in murine embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

Control of developmental regulators by Polycomb in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

Role of histone H3 lysine 27 methylation in Polycomb-group silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

Histone methyltransferase activity of a Drosophila Polycomb group repressor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

The Polycomb group protein EZH2 directly controls DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

The polycomb group protein EZH2 is involved in progression of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

What is the molecular pathology of low-risk prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

Ezh2 reduces the ability of HDAC1-dependent pRb2/p130 transcriptional repression of cyclin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

CDKN1C (p57) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

Repression of E-cadherin by the polycomb group protein EZH2 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

Enhancer of zeste homolog 2 downregulates E-cadherin by mediating histone H3 methylation in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

Immunohistochemical evaluation of pRb2/p130, VEGF, EZH2, p53, p16, p21waf-1, p27, and PCNA in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

inferred from DOI database lookup

7 January 2021

based on heuristic

Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26441

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.26441

1 reference

12 September 2017

1 reference